-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeUSDISIN US7170811035-
PfizerBörse NYSE New York Stock ExchangeISIN US7170811035 WKN: 852009USDSymbol PFE
-
PfizerBörse Börse StuttgartISIN US717081DK61EURSymbol PFE
-
PfizerBörse Xetra FrankfurtISIN US717081ER06EURSymbol PFE
-
PFIZER INCBörse Börse HamburgISIN US717081ED10EURSymbol PFE
-
PFIZER INCBörse Börse DüsseldorfISIN XS1574158082EURSymbol PFE
-
PFIZER INCBörse Börse MünchenISIN US717081DZ31EURSymbol PFE
-
PFIZER INCBörse Gettex System der Börse MünchenISIN US717081ES88EURSymbol PFE
-
PFIZER INCBörse Tradegate System der Deutsche Börse AG (60%)ISIN US717081EQ23EURSymbol PFE
-
PFIZER INCBörse Quotrix System der Börse DüsseldorfISIN US717081DE02EURSymbol PFE
-
PFIZER INCBörse Börse FrankfurtISIN XS1574157357EURSymbol PFE
-
PfizerBörse Xetra FrankfurtEURISIN US717081EY56
-
PfizerBörse Börse MünchenEURISIN US717081FA61
-
PfizerBörse SSE Stockholm Stock ExchangeISIN US717081EZ22SEKSymbol PFE
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US717081EK52MXNSymbol PFE
-
PfizerBörse Bolsa de Comercio de Buenos AiresUSDISIN US717081DV27
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US717081DH33
-
PfizerBörse BUEUSDISIN US717081EV18
-
ISIN US717081EX73EURSymbol PFE
-
PfizerBörse OMXSSEKISIN US7170811035
-
EURISIN US717081EJ89
-
PFIZER INCBörse SSEISIN US717081EP40
-
ISIN US7170811035
WKN 852009
Symbol PFE
Währung
USD
Börse
NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Firmenname
Pfizer Inc
Marktkapitalisierung
197.500.079.920 (+- 10%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
204.882.624.512 oder 216.419.000.000 oder 171.198.615.249
Mitarbeiter
83.400 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
88.300 oder 78.500 Mitarbeiter
Anzahl Aktien
5.558.396.599
KGV
18.68 (+- 28%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
23.97 oder 13.4
EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744
Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 4,02 % p. a.
beim aktuellen Kurs von 36,59 USD -0,04%
Pfizer underperformed den DAX um -13 % (+31 % Dividenden) vom 06.12.2013 bis 14.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 36,59 USD -0,04%
Letzte Communitymeinungen
- 2 User waren zuletzt bullisch
- Im Alpha-Tester Battle 2021
-
casixxx
-
Harry386
Ein User hat Pfizer abonniert.
Aktionärsstruktur der Pfizer Inc
Portrait der Pfizer Aktie
Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.
Die Pfizer Aktie hat inklusive der Dividendenausschüttungen seit dem 06.12.2013 eine Gesamtrendite von 88% erwirtschaftet
Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
1.048 News & Informationen zur Pfizer Aktie
As Covid Cases Surge, South Africa Eschews Weekend Vaccinations
(Bloomberg) — South Africa’s nascent vaccination rollout has drawn heavy criticism for only administering doses on weekdays — even as a third wave of coronavirus infections rips through the nation.
Could Vertex Pharmaceuticals Be a Prime Acquisition Target?
It's not out of the question.
Those who get infected by COVID-19 after vaccines carry less viral load, study finds
The findings provide further evidence supporting what health authorities promoting vaccinations have been saying for months.
'I saw Facebook posts': Vaccine disinformation endangers millions in Asia
Read more about 'I saw Facebook posts': Vaccine disinformation endangers millions in Asia on Business Standard. False claims are fueling vaccine hesitancy in pockets, undermining efforts to vaccinate some of the most vulnerable people in Asia.
Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206
CAMBRIDGE, Mass., June 30, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (NASDAQ:SPRO) – a multi-asset clinical-stage biopharmaceutical company focused …
Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206
Spero grants Pfizer rights to develop, manufacture, and commercialize SPR206 in ex-U.S. and ex-Asia territories in exchange for potential development and…
Top Biotech Companies by Market Cap
What are the biggest names in biotechnology? We count down the five top biotech companies based on market cap and share what they're up to.
Clinical Nutrition Market In The Personal Products Industry To Grow By $ 22.20 Bn Through 2025 |Technavio
NEW YORK, June 30, 2021 /PRNewswire/ —
Technavio offers an up-to-date analysis regarding the current global market scenario and the overall market
Brazil suspends $320 million deal with Bharat Biotech for Covaxin
The firm denies any wrongdoing in the contract for the vaccine, including the pricing.The Brazilian government’s role in procuring Covaxin has been under scrutiny, given the price, at $15 per dose, is the highest for any vaccine
3 Pharma Stocks with Tremendous Growth Potential By StockNews
3 Pharma Stocks with Tremendous Growth Potential
Moderna Gives Growth Investors a Lot to Like Even as Vaccination Rates Rise
With a gain of 265% in the last 12 months, there's growing sentiment that MRNA stock is due for a correction. Short-term investors may want to stay aw…
2 Unstoppable Stocks to Buy No Matter What Happens in the Second Half of the Year
These two pharma companies can weather whatever storm is coming our way.
1 Thing Investors Should Watch That Could Disrupt the COVID Vaccine Market
The major vaccine makers are definitely watching it.
3 Reasons Shareholders of Moderna and BioNTech May Be In for a Shock
A recent study undermines one key assumption underpinning the stocks' recent gains.
Is Novavax the Leader in Developing a Combo COVID/Flu Vaccine?
For now, at least, the answer appears to be “yes.”
Is Pfizer's Partner BioNTech About to Make a Big Blunder?
It's only a maybe at this point.
Revel's Ribbon Cutting Ceremony To Celebrate The Opening Of Its First Electric Vehicle (EV) Fast Charging Superhub In Brooklyn. (Photo: Business Wire)
Electric transportation company Revel opened its first electric vehicle (EV) fast charging Superhub to the public today at the historic former Pfizer building
Heart inflammation after COVID-19 shots higher-than-expected in study of U.S. military By Reuters
Heart inflammation after COVID-19 shots higher-than-expected in study of U.S. military
Here's Why Cerevel Therapeutics Stock Is Shooting Through the Roof Today
Positive topline results from the company's schizophrenia candidate were better than expected.
Sanofi to invest in mRNA vaccines development By Reuters
Sanofi to invest in mRNA vaccines development
3 Reasons to Buy BioNTech, And 1 Reason To Sell
Despite the vaccine windfall and an impressive pipeline, shareholders might need the company's encore sooner than expected.
Sanofi bets on mRNA vaccines after covid-19 pandemic shows worth
One of the world’s biggest vaccine makers, it plans to invest some $477 million a year to catch up in the new gene-based technology
After Moderna, India likely to close deal with Pfizer Covid vaccine: Govt
Last week Pfizer's chief executive Albert Bourla said that the company was in the final stages to get approval for the coronavirus vaccine in India.On Tuesday, the DCGI granted approval to Cipla Ltd to import the COVID-19 vaccine developed by Moderna Inc
Why a Top European Official Is Warning to Avoid AstraZeneca's COVID Vaccine
The big drugmaker now faces another challenge for its COVID-19 vaccine.
Why Pfizer Halted Shipments of 1 of Its Top-Selling Products
The drugmaker could lose millions of dollars, but investors don't seem to be worried.
EMEA Morning Briefing : Worries Over Rising Covid -2-
Iron ore prices were almost 1% higher in China, as the commodity continued to recover from last week's retreat. The metal's recent decline has been driven by lower demand from steelmakers amid…
Three Australian cities lock down in fight against Delta COVID-19 variant By Reuters
Three Australian cities lock down in fight against Delta COVID-19 variant
Dose Mixing Shows Strong Response; U.K. Cases Jump: Virus Update
(Bloomberg) — Mixing doses of Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc creates a strong immune response, according to results from a University…
Full FDA approval of Pfizer’s and Moderna’s COVID-19 shots would reinvigorate the U.S. vaccination push — but it could still be months away
The
Record broken last week for immunizations
More than 78% of British Columbians have now been vaccinated at least once against COVID-19, as B.C. readies itself for a significant milestone in its phased reopening: stage 3.
Intellia Shares Soar on Positive Test Results
GuruFocus Article or News written by Barry Cohen and the topic is about: Merck, Sanofi, Gilead and others stand to benefit from clinical trials
U.S. administers 324 million doses of COVID-19 vaccines
U.S. administers 324 million doses of COVID-19 vaccines – CDC
Mix-and-match approach boosts immune response of AstraZeneca shot, study finds By Reuters
Mix-and-match approach boosts immune response of AstraZeneca shot, study finds
Astra Vaccine Response Higher With Longer Gap, Third Dose
Immune responses to the AstraZeneca Plc Covid-19 vaccine improve with a longer gap of up to 45 weeks between doses, with a third shot able to boost antibody levels even further, according to a study.
Outlook on the Injectables Global Market to 2025 – Upsurge in Demand for Convenient Drug Delivery is Driving the Industry
DUBLIN, June 28, 2021 /PRNewswire/ — The 'Global Injectables Market: Insights & Forecast with Potential Impact of COVID-19 (2021-2025)' report ha…
Global Infusion Pumps Market (2021 To 2025) – Leading Players Include Pfizer, Fresenius And Baxter International
DUBLIN, June 28, 2021 /PRNewswire/ — The “Global Infusion Pumps Market (by Type, Product, Technology, Application, End-user & Region): Insights & Forecast
Global Infusion Pumps Market (2021 to 2025) – Leading Players Include Pfizer, Fresenius and Baxter International
/PRNewswire/ — The “Global Infusion Pumps Market (by Type, Product, Technology, Application, End-user & Region): Insights & Forecast with Potential Impact of…
Antares Pharma Announces Partner Idorsia Initiates The Phase 3 Study With Selatogrel For Acute Myocardial Infarction
EWING, N.J., June 28, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. ATRS (“the Company”), a specialty pharmaceutical company, today announced that its partner
Astra Vaccine Response Higher With Longer Gap, Third Dose
(Bloomberg) — Immune responses to the AstraZeneca Plc Covid-19 vaccine improve with a longer gap of up to 45 weeks between doses, with a third shot able to boost antibody levels even further, according to a study.
Protalix BioTherapeutics to Participate in a Fireside Chat on June 30, 2021
/PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and…